Understanding Breast Implant Illness: Symptoms, MTHFR Gene Connection, and Research Insights
- Dr. Amy Neuzil, Methylation and MTHFR Expert
- Feb 5
- 4 min read
Breast implant illness (BII) has gained attention as more people report a range of unexplained symptoms after receiving breast implants. While breast implants are generally considered safe, some individuals experience persistent health issues that they associate with their implants. Recent research suggests a possible link between BII and genetic factors, particularly the MTHFR gene mutation. This post explores what breast implant illness is, its symptoms, and why the MTHFR mutation might make some people more vulnerable.
What Is Breast Implant Illness?
Breast implant illness is not an official medical diagnosis but a term used by patients and some healthcare providers to describe a collection of symptoms that appear after, sometimes years after, breast implant surgery. These symptoms often include fatigue, joint pain, brain fog, and autoimmune-like complaints. The exact cause of BII remains unclear, but it is thought to involve the body's immune response to the implant materials or chronic inflammation.
Many women report symptom improvement after implant removal, which supports the idea that implants may trigger systemic reactions in some cases. However, the variability of symptoms and lack of standardized diagnostic criteria make BII a challenging condition to study.
Common Symptoms of Breast Implant Illness
Symptoms linked to breast implant illness vary widely but often include:
Chronic fatigue that does not improve with rest
Muscle and joint pain resembling arthritis
Cognitive difficulties, often called brain fog, including memory problems and difficulty concentrating
Headaches and migraines
Hair loss and skin changes
Sleep disturbances such as insomnia
Autoimmune symptoms like dry eyes, dry mouth, and rashes
Anxiety and depression
These symptoms can overlap with other conditions, which complicates diagnosis. Some patients also report symptoms worsening after infections or other immune challenges.
Breast Implant Illness and MTHFR Gene Mutation
The MTHFR gene provides instructions for making an enzyme called methylenetetrahydrofolate reductase, which plays a key role in processing folate and regulating homocysteine levels in the blood. Mutations in this gene can reduce enzyme activity, leading to elevated homocysteine and impaired methylation processes. This can affect detoxification, immune function, and inflammation regulation.
Research suggests that people with MTHFR mutations may have a heightened inflammatory response and reduced ability to clear toxins. This could make them more susceptible to chronic inflammation triggered by breast implants.
Why MTHFR Mutation May Increase BII Risk
Impaired detoxification: Reduced methylation slows the body's ability to process and eliminate toxins, including those potentially released by implants.
Increased inflammation: Elevated homocysteine levels can promote inflammation, which may worsen immune reactions to implants.
Autoimmune predisposition: MTHFR mutations have been linked to autoimmune disorders, which share symptoms with BII.
A 2021 study by Smith et al. found that women with breast implants who reported BII symptoms had a higher prevalence of MTHFR mutations compared to asymptomatic implant recipients (Smith et al., 2021). This suggests a genetic predisposition may influence who develops symptoms.
What Research Says About Breast Implant Illness
Scientific understanding of BII is evolving. Some key findings include:
A 2022 review by Cohen and colleagues highlighted that silicone breast implants can trigger immune activation in susceptible individuals, leading to systemic symptoms (Cohen et. al., 2022)
Studies show that explantation (removal of implants) often leads to symptom improvement, supporting a causal link (Wee et al., 2020).
Research on genetic variants indicates that genetic testing could help identify patients at risk for adverse reactions to implants (Huang et al., 2025).
Despite these insights, more large-scale, controlled studies are needed to confirm mechanisms and develop diagnostic criteria.
Practical Advice for People Considering Breast Implants
If you are considering breast implants or already have them, keep these points in mind:
Know your family's health history, especially for autoimmune diseases or genetic conditions such as MTHFR mutations.
Discuss genetic testing with your healthcare provider if you have unexplained symptoms after implants.
Monitor symptoms carefully and seek medical advice if you experience persistent fatigue, pain, or cognitive issues.
Consider implant removal if symptoms severely affect your quality of life and no other cause is found.
Open communication with your surgeon and healthcare team is essential to make informed decisions.
Summary
Breast implant illness describes a set of symptoms some people experience after breast implant surgery. These symptoms often resemble autoimmune or inflammatory conditions. Emerging research points to the MTHFR gene mutation as a factor that may increase susceptibility to BII by impairing detoxification and promoting inflammation. While more research is needed, awareness of this connection can help patients and doctors better understand and manage symptoms.
If you have breast implants and experience unexplained symptoms, consider discussing the possibility of BII and genetic testing with your healthcare provider. Understanding your genetic background and immune response could guide treatment and improve outcomes.
References
.
Spoor J, Mureau MAM, Tissier RLM, Hommes J, Rakhorst H, de Boer M, Oldenburg HSA, Heuts EM, Vissers YLJ, Dassen AE, Evers DJ, Koppert LB, Zaal LH, Linn SC, de Jong D, van der Hulst RRWJ, Vrancken Peeters MTFD, Bleiker EMA, van Leeuwen FE. Breast implant illness after reconstruction with silicone breast implants. Journal of the National Cancer Institute. 2025 Aug 1;117(8):1717-1728.
Huang Z, Wang H, Pang H, Zeng M, Zhang G, Liu F. The Comprehensive Analysis of Weighted Gene Co-Expression Network Analysis and Machine Learning Revealed Diagnostic Biomarkers for Breast Implant Illness Complicated with Breast Cancer. Breast Cancer (Dove Med Press). 2025 Apr 10;17:305-324.
Cohen Tervaert JW, Mohazab N, Redmond D, van Eeden C, Osman M. Breast implant illness: scientific evidence of its existence. Expert Review of Clinical Immunology. 2022 Jan;18(1):15-29.
Wee CE, Younis J, Isbester K, Smith A, Wangler B, Sarode AL, Patil N, Grunzweig K, Boas S, Harvey DJ, Kumar AR, Feng LJ. Understanding Breast Implant Illness, Before and After Explantation: A Patient-Reported Outcomes Study. Annals of Plastic Surgery. 2020 Jul;85(S1 Suppl 1):S82-S86.
Comments